Compare
Sintx Technologies, Inc. vs Femasys Inc vs OSR Health, Inc. vs Sensus Healthcare, Inc.
| Latest fiscal year | Sintx Technologies, Inc. SINT | Femasys Inc FEMY | OSR Health, Inc. OSRH | Sensus Healthcare, Inc. SRTS |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.02M | $2.29M | $2.91M | $27.48M |
| Revenue growth (YoY) | -64.7% | +40.8% | -17.7% | -34.3% |
| Gross margin | 45.3% | 62.0% (computed) | 20.4% | 43.2% |
| Operating margin | n/m | -767.0% | -631.0% | -37.5% |
| Net margin | n/m | -812.3% | -931.2% | -28.1% |
| Net income | -$10.36M | -$18.63M | -$27.06M | -$7.72M |
| EPS (Diluted) | -$6.16 | -$0.47 | -$0.80 | -$0.47 |
| Operating cash flow | -$8.57M | -$18.69M | -$4.33M | $528.0K |
| Free cash flow | -$8.76M | -$19.22M | n/a | $332.0K |
| Cash & equivalents | $4.14M | $9.27M | $1.70M | $22.08M |
| Total assets | $9.51M | $20.72M | $171.24M | $53.04M |
| Total liabilities | $6.58M | $14.85M | $44.20M | $4.94M |
| Shareholders' equity | $2.93M | $5.87M | $127.04M | $48.10M |
| Return on year-end equity | -353.8% | -317.4% | -21.3% | -16.0% |
| Shares outstanding | 3.97M | 59.60M | 26.60M | 16.46M |
Revenue, most recent five fiscal years
| Fiscal year | Sintx Technologies, Inc. | Femasys Inc | OSR Health, Inc. | Sensus Healthcare, Inc. |
|---|---|---|---|---|
| Latest | $1.02M Ended 2025-12-31 | $2.29M Ended 2025-12-31 | $2.91M Ended 2025-12-31 | $27.48M Ended 2025-12-31 |
| 1 year earlier | $2.89M Ended 2024-12-31 | $1.63M Ended 2024-12-31 | $3.53M Ended 2024-12-31 | $41.81M Ended 2024-12-31 |
| 2 years earlier | $2.63M Ended 2023-12-31 | $1.07M Ended 2023-12-31 | n/a | $24.41M Ended 2023-12-31 |
| 3 years earlier | $1.56M Ended 2022-12-31 | $1.21M Ended 2022-12-31 | n/a | $44.53M Ended 2022-12-31 |
| 4 years earlier | $606.0K Ended 2021-12-31 | $1.18M Ended 2021-12-31 | n/a | $27.04M Ended 2021-12-31 |